Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Steven A. Soper

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8292-7058; OpenAlex author ID A5038208939. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC). Co-author DOI 10.1093/oncolo/oyag225↗
  2. Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. Last author DOI 10.3390/cells12182266↗
  3. Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma. Co-author DOI 10.1371/journal.pone.0089474↗
  4. Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer. Last author DOI 10.1021/ac401720k↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weijing Sun · 2 shared papers, 2023–2026 · strength 0.38
  2. Anup Kasi · 2 shared papers, 2023–2026 · strength 0.38
  3. Anwaar Saeed · 1 shared paper, 2026 · strength 0.23
  4. Ian M. Freed · 1 shared paper, 2023 · strength 0.15
  5. Joyce W. Kamande · 2 shared papers, 2013–2014 · strength 0.08
  6. Robert J. Torphy · 2 shared papers, 2013–2014 · strength 0.08
  7. Jen Jen Yeh · 2 shared papers, 2013–2014 · strength 0.08
  8. Richard A. Moffitt · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.